PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
85.63%
Net income growth 1.25-1.5x CRON.TO's 75.58%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-16.43%
Both reduce yoy D&A, with CRON.TO at -8.31%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
107.77%
Deferred tax of 107.77% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
2.50%
SBC growth while CRON.TO is negative at -43.91%. John Neff would see competitor possibly controlling share issuance more tightly.
-179.58%
Both reduce yoy usage, with CRON.TO at -261.97%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
43.02%
AR growth is negative or stable vs. CRON.TO's 311.20%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
99.21%
Some inventory rise while CRON.TO is negative at -129.30%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-148.84%
Negative yoy AP while CRON.TO is 44.06%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-692.22%
Both reduce yoy usage, with CRON.TO at -236.01%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-95.18%
Both negative yoy, with CRON.TO at -71.28%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-125.44%
Both yoy CFO lines are negative, with CRON.TO at -95.69%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
46.37%
Some CapEx rise while CRON.TO is negative at -4.69%. John Neff would see competitor possibly building capacity while we hold back expansions.
96.07%
Acquisition growth of 96.07% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2960.30%
Growth well above CRON.TO's 90.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
68.73%
We have mild expansions while CRON.TO is negative at -291.73%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
93.35%
Debt repayment growth of 93.35% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-50.63%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.